Amit Gupta Sells $70.9K of Cardlytics Inc (CDLX) — SEC Form 4, Jul 06, 2026
Open-Market Net Sale · SEC Form 4
−$70,917
Equity position changed by +13.2%
Equity Position
130K sh
114,876 → 129,988
Equity Change
+13.2%
shares held after vs before
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Amit Gupta CIK 0001961238 |
Director
CEO
|
Amit Gupta at Cardlytics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$468,364
More from this insider at Cardlytics Inc
| 2026-10-02 | Sell | -$46,750 | View |
| 2026-08-18 | Sell | -$53,820 | View |
| 2026-04-06 | Sell | -$82,892 | View |
| 2026-04-02 | Sell | -$118,426 | View |
| 2026-03-03 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1F2 | 2026-07-01 | M - Exercise | 12,500 A | — | 111,238 | Direct | |
| Common StockF1 | 2026-07-01 | M - Exercise | 18,750 A | — | 129,988 | Direct | |
| Common StockF3 | 2026-07-02 | S - Sale | 6,498 D | $4.40 | -$28,559 | 123,490 | Direct |
| Common StockF4 | 2026-07-06 | S - Sale | 9,640 D | $4.39 | -$42,358 | 113,850 | Direct |
Derivative Securities Transactions
Footnotes (6)
- F1
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. Show more
- F2
- Effective June 5, 2026, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split. Show more
- F3
- The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.260 to $4.540, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). Show more
- F4
- The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $4.280 to $4.510, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4). Show more
- F5
- 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Show more
- F6
- The RSU award will vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. Show more
Related filings at Cardlytics Inc
Institutional Holders
13F holders · Jun 30, 2026
1
institutional managers reporting a position
Largest by reported value
- Cas Investment Partners, Llc $2.11M
5%+ Holders · 13D/G
1 filer
Other insiders at Cardlytics Inc
GET /v1/forms/4/0001628280-26-047392
API docs
View Original SEC Filing